
Evercore ISI initiated coverage on Accenture (ACN) with an Outperform rating and a $330 price target, citing the company's strong positioning for the AI-led technology transition and viewing its nearly 20% year-to-date underperformance as a buying opportunity. The firm projects significant medium-term EPS upside and sustained growth driven by anticipated multi-year AI tailwinds, underpinned by Accenture's robust fundamentals, strong free cash flow, and current valuation discount, a sentiment echoed by recent strategic moves and strong generative AI bookings.
Evercore ISI has initiated coverage on Accenture (ACN) with an Outperform rating and a $330 price target, framing the stock's 19.37% year-to-date decline as a compelling buying opportunity. The core of the bullish thesis rests on Accenture's strong positioning to guide enterprises through the current AI-led technology cycle, a catalyst Evercore believes could mirror the multi-year tailwinds seen during the cloud proliferation era. This view is supported by projections for mid-to-high single-digit sales growth, 30-50 basis points of annual margin expansion, and double-digit EPS growth in the medium term. The company's fundamental strength is underscored by a strong free cash flow conversion of approximately 130% of net income, which facilitates strategic M&A. This positive outlook is echoed across the street, with UBS reiterating a Buy rating based on generative AI bookings reaching $1.5 billion in Q3 and an acquisition of SYSTEMA, while Stifel also maintained its Buy rating. A note of caution comes from TD Cowen, which, despite a Buy rating, trimmed its price target to $342, citing light bookings and segment-specific challenges. The stock's current valuation at a P/E of 22.01 represents a discount to its historical average, suggesting potential for multiple expansion as the AI narrative solidifies.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment